AAAAAA
Results:
1-16
|
Results: 16
Authors:
Pujade-Lauraine, E
Cure, H
Battista, C
Guastalla, JP
Chiurazzi, B
Fabbro, M
Tubiana-Mathieu, N
Bourgeois, H
Lioure, B
Paraiso, D
Lotz, JP
Citation: E. Pujade-lauraine et al., High dose chemotherapy in ovarian cancer, INT J GYN C, 11, 2001, pp. 64-67
Authors:
Maindrault-Goebel, F
de Gramont, A
Louvet, C
Andre, T
Carola, E
Mabro, M
Artru, P
Gilles, V
Lotz, JP
Izrael, V
Krulik, M
Citation: F. Maindrault-goebel et al., High-dose intensity oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX 7), EUR J CANC, 37(8), 2001, pp. 1000-1005
Authors:
Ledermann, JA
Herd, R
Maraninchi, D
Viens, P
Buclon, M
Philip, T
Cure, H
Lotz, JP
Chauvin, F
Ferrante, P
Rosti, G
Citation: Ja. Ledermann et al., High-dose chemotherapy for ovarian carcinoma: Long-term results from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT), ANN ONCOL, 12(5), 2001, pp. 693-699
Authors:
Trillet-Lenoir, V
Lotz, JP
Le Cesne, A
Roy, P
Edouard, A
Citation: V. Trillet-lenoir et al., Reflexions from the experience of the French CLEOPATRE program and concerns about the status of clinical research on small cell lung cancer, LUNG CANC, 33(2-3), 2001, pp. 303-307
Cytokines and vascular cell adhesion molecule-1 in the blood of patients undergoing HPC mobilization
Authors:
Dosquet, C
Chen, Y
Makke, J
Miclea, JM
Coudert, MC
Marolleau, JP
Fermand, JP
Cottu, P
Lotz, JP
Benbunan, M
Citation: C. Dosquet et al., Cytokines and vascular cell adhesion molecule-1 in the blood of patients undergoing HPC mobilization, TRANSFUSION, 41(2), 2001, pp. 206-212
Authors:
Maindrault-Goebel, F
de Gramont, A
Louvet, C
Andre, T
Carola, E
Gilles, V
Lotz, JP
Tournigand, C
Mabro, M
Molitor, JL
Artru, P
Izrael, V
Krulik, M
Citation: F. Maindrault-goebel et al., Evaluation of oxaliplatin dose intensity in bimonthly leucovorin and 48-hour 5-fluorouracil continuous infusion regimens (FOLFOX) in pretreated metastatic colorectal cancer, ANN ONCOL, 11(11), 2000, pp. 1477-1483
Authors:
Andre, T
Balosso, J
Louvet, C
Hannoun, L
Houry, S
Huguier, M
Colonna, M
Lotz, JP
De Gramont, A
Bellaiche, A
Parc, R
Touboul, E
Izrael, V
Citation: T. Andre et al., Combined radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) as palliative treatment for localized unresectable or adjuvant treatment for resected pancreatic adenocarcinoma: Results of a feasibility study, INT J RAD O, 46(4), 2000, pp. 903-911
Authors:
Yanovich, S
Mitsky, P
Cornetta, K
Maziarz, RT
Rosenfeld, C
Krause, DS
Lotz, JP
Bitran, JD
Williams, B
Preti, R
Somlo, G
Burtness, B
Mills, B
Citation: S. Yanovich et al., Transplantation of CD34(+) peripheral blood cells selected using a fully automated immunomagnetic system in patients with high-risk breast cancer: results of a prospective randomized multicenter clinical trial, BONE MAR TR, 25(11), 2000, pp. 1165-1174
Authors:
Lotz, JP
Lhomme, C
Pautier, P
Couteau, C
Gligorov, J
Alexandre, J
Selle, F
Izrael, V
Maraninchi, D
Viens, P
Citation: Jp. Lotz et al., High-dose chemotherapy in ovarian adenocarcinoma, B CANCER, 87(1), 2000, pp. 63-69
Authors:
Edelman, L
Durand, JC
Lotz, JP
Validire, P
Monchatre, E
Bayle, C
Arnoulet, C
Sainty, D
Citation: L. Edelman et al., Tumor cells in breast tumors: significance of their presence for prognosis, HEM CELL TH, 41(2), 1999, pp. 66-70
Authors:
Lotz, JP
Cure, H
Janvier, M
Morvan, F
Legros, M
Asselain, B
Guillemot, M
Roche, H
Gisselbrecht, C
Citation: Jp. Lotz et al., High-dose chemotherapy with autologous hematopoietic stem cell support formetastatic breast cancer: Results of the French Pegase 04 protocol, HEM CELL TH, 41(2), 1999, pp. 71-74
Authors:
Ghazli, M
Sananes, S
Chopier, J
Touboul, E
Lotz, JP
Antoine, M
Antoine, JM
Uzan, S
Citation: M. Ghazli et al., Inflammatory and/or locally advanced breast cancer, CONTR FER S, 27(12), 1999, pp. 872-876
Authors:
Maindrault-Goebel, F
Louvet, C
Andre, T
Carola, E
Lotz, JP
Molitor, JL
Garcia, ML
Gilles-Amar, V
Izrael, V
Krulik, M
de Gramont, A
Citation: F. Maindrault-goebel et al., Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6), EUR J CANC, 35(9), 1999, pp. 1338-1342
Authors:
Andre, T
Louvet, C
Maindrault-Goebel, F
Couteau, C
Mabro, M
Lotz, JP
Gilles-Amar, V
Krulik, M
Carola, E
Izrael, V
de Gramont, A
Citation: T. Andre et al., CPT-11 (irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer, EUR J CANC, 35(9), 1999, pp. 1343-1347
Authors:
Touboul, E
Buffat, L
Belkacemi, Y
Lefranc, JP
Uzan, S
Lhuillier, P
Faivre, C
Huart, J
Lotz, JP
Antoine, M
Pene, F
Blondon, J
Izrael, V
Laugier, A
Schlienger, M
Housset, M
Citation: E. Touboul et al., Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer, INT J RAD O, 43(1), 1999, pp. 25-38
Authors:
Marolleau, JP
Dal Cortivo, L
Mills, B
Fermand, JP
Miclea, JM
Lotz, JP
Gisselbrecht, C
Benbunan, M
Citation: Jp. Marolleau et al., Enrichment of peripheral blood CD34(+) cells for transplantation using a fully automated immunomagnetic cell selection system and a novel octapeptidereleasing agent, BONE MAR TR, 23(8), 1999, pp. 819-826
Risultati:
1-16
|